Precision Optics (NASDAQ:POCI – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a note issued to investors on Saturday.
Separately, Weiss Ratings raised shares of Precision Optics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, June 5th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Precision Optics presently has a consensus rating of “Sell”.
Read Our Latest Report on POCI
Precision Optics Stock Performance
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in POCI. Jane Street Group LLC acquired a new position in shares of Precision Optics during the fourth quarter valued at about $48,000. Citadel Advisors LLC bought a new stake in shares of Precision Optics in the third quarter valued at approximately $49,000. DRW Securities LLC purchased a new stake in shares of Precision Optics during the 4th quarter valued at approximately $94,000. Geode Capital Management LLC lifted its stake in shares of Precision Optics by 3.4% during the 4th quarter. Geode Capital Management LLC now owns 58,436 shares of the company’s stock valued at $245,000 after buying an additional 1,926 shares in the last quarter. Finally, WealthTrust Axiom LLC boosted its holdings in Precision Optics by 2.7% in the 4th quarter. WealthTrust Axiom LLC now owns 231,808 shares of the company’s stock worth $970,000 after buying an additional 6,158 shares during the period. 13.71% of the stock is owned by institutional investors.
Precision Optics Company Profile
Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.
Featured Stories
- Five stocks we like better than Precision Optics
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.
